UK Companies House feature
COLE-PARMER LIMITED
Profile
- Company number
- 06381141
- Status
- Active
- Incorporation
- 2007-09-25
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After making appropriate enquiries including consideration of the current macroeconomic climate, and the financial position and performance of the CPI Buyer LLC Group, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future and have received written assurances from CPI Buyer LLC, an intermediate parent company, that they will continue to provide support for at least 12 months from the date of approval of these financial statements.”
Subsidiaries
- PCR Max Limited · 100% held · UK · Holding company
- SPEX CertiPrep Ltd. · 100% held · UK · Holding company
- Bibby Scientific (Hong Kong) Co Limited · 100% held · Hong Kong · Holding company
- Cole-Parmer Laboratory Equipment (Shanghai) Co., Ltd. · 100% held · PRC China · Scientific Equipment
- CPI Chiron Acquisition AS · 100% held · Norway · Holding company
- Chiron AS · 100% held · Norway · Scientific Chemical Solutions
- Chiron Pharmasynth AS · 100% held · Norway · Scientific Chemical Solutions
- Oil Well Technologies AS · 100% held · Norway · Scientific Chemical Solutions
- Chiron (UK) Limited · 100% held · UK · Scientific Chemical Solutions
Significant events
- “On 28 May 2025, Brookfield Asset Management Inc., through its private equity arm, and Caisse de dépôt et placement du Québec (CDPQ), completed the acquisition of Antylia Scientific, the ultimate parent company of Cole-Parmer Instrument Company Limited, in an all-cash transaction valued at approximately $1.34 billion.”
- “Antylia Scientific, formerly known as Cole-Parmer, is a diversified life sciences tools business headquartered in Vernon Hills, Illinois, USA. The acquisition marks the conclusion of a decade-long ownership by GTCR, a private equity firm that originally acquired the business in 2014 from Thermo Fisher Scientific.”
- “The transaction was completed after the date of the Statement of Financial Position and does not impact the financial position of Cole-Parmer Instrument Company Limited as at 31 December 2024. However, it represents a significant change in the ownership structure of the Group and may influence future strategic direction, investment priorities, and operational synergies.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2015-10-14 | — | — |
| RINALDI, Philip | Director | 2019-05-08 | Aug 1963 | British |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MORTON, John George | Secretary | 2007-10-23 | 2007-12-06 |
| JAMESTOWN INVESTMENTS LIMITED | Corporate Secretary | 2007-12-06 | 2015-10-14 |
| TRAVERS SMITH SECRETARIES LIMITED | Corporate Secretary | 2007-09-25 | 2007-10-23 |
| BRUST, Bernd | Director | 2015-10-14 | 2025-05-27 |
| GALLIFANT, Jamie Ronald | Director | 2018-03-10 | 2019-05-08 |
| HEFFERNAN, James Gerard, Dr | Director | 2010-09-07 | 2015-10-14 |
| JONES, Kathryn Ada | Director | 2007-10-23 | 2008-04-24 |
| LEADER, Thomas William | Director | 2015-07-07 | 2015-10-14 |
| NEVIN, Michael Eric | Director | 2007-12-17 | 2015-07-07 |
| ROBSON, Adam David | Director | 2007-10-23 | 2015-04-12 |
| SALKIN, Jon | Director | 2018-03-10 | 2026-01-12 |
| WALDES, Andrew Timothy, Mr. | Director | 2015-10-14 | 2018-03-10 |
| WILLIAMSON, David Simon | Director | 2007-10-23 | 2008-04-24 |
| TRAVERS SMITH DIRECTORS LIMITED | Corporate Director | 2007-09-25 | 2007-10-23 |
| TRAVERS SMITH SECRETARIES LIMITED | Corporate Director | 2007-09-25 | 2007-10-23 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Uk Boxer Midco 2 Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 140 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-02-20 | TM01 | officers | termination director company with name termination date |
| 2026-01-07 | AA | accounts | accounts with accounts type full |
| 2025-09-25 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-07-01 | TM01 | officers | termination director company with name termination date |
| 2024-10-10 | AA | accounts | accounts with accounts type full |
| 2024-09-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-10-13 | AA | accounts | accounts with accounts type full |
| 2023-09-26 | RESOLUTIONS | resolution | resolution |
| 2023-09-25 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-08-31 | SH01 | capital | capital allotment shares |
| 2023-01-06 | AA | accounts | accounts with accounts type full |
| 2022-10-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-03-02 | DISS40 | gazette | gazette filings brought up to date |
| 2022-03-01 | GAZ1 | gazette | gazette notice compulsory |
| 2022-02-23 | AA | accounts | accounts with accounts type full |
| 2021-10-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-08-26 | AA | accounts | accounts with accounts type full |
| 2020-11-13 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-11-28 | AA | accounts | accounts with accounts type full |
| 2019-10-03 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory